Home/Pipeline/Bosimi® Platform

Bosimi® Platform

Continuous blood pressure monitoring in adult inpatient and emergency care

DevelopmentActive

Key Facts

Indication
Continuous blood pressure monitoring in adult inpatient and emergency care
Phase
Development
Status
Active
Company

About PyrAmes

PyrAmes is a private, commercial-stage medical device company pioneering continuous non-invasive blood pressure (cNIBP) monitoring. Its core innovation is a wireless, calibration-free sensor technology that provides accurate, real-time blood pressure data, initially focused on the vulnerable neonatal and pediatric intensive care population with its FDA 510(k)-cleared Boppli® platform. The company is now developing its technology for adult inpatient (Bosimi®) and home diagnostic (Bosimi@Home™) markets, targeting a massive global need driven by hypertension and critical care monitoring gaps. Backed by recognition from the NIH, AHA, and FDA Breakthrough Device designation, PyrAmes is positioned to transform a foundational vital sign measurement.

View full company profile